Agency abruptly withdraws plan to require standardized asbestos testing • Move contradicts congressional mandate in 2022 ...
The U.S. Food and Drug Administration on Tuesday extended its review of Ascendis Pharma's therapy for children with a rare ...
As the FDA's Commissioner's National Priority Voucher (CNPV) program has picked up steam, with 15 companies now having ...
MedPage Today on MSN
FDA Gives Broad Approval to Gene Therapy for Rare Neurologic Disease
The FDA approved the intrathecal gene therapy onasemnogene abeparvovec (Itvisma) to treat spinal muscular atrophy (SMA) in ...
The FDA has approved durvalumab (Imfinzi) plus fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for the treatment ...
Boar’s Head Grated Pecorino Romano Cheese, Locatelli Pecorino Romano Grated Cheese and wedges of Boar's Head Pecorino Romano ...
See the full November 2025 FDA recalls list, including Boar's Head Chicken Caesar Salad, Haagen-Dazs bars, baby formula and ...
The U.S. Food and Drug Administration has approved Otsuka's injectable drug to treat patients with a potentially ...
The change removes several major safety notices from common hormone products, but doctors say decisions should remain ...
Through our Venable FDA Pulse series, we provide insight into key developments within the Food and Drug Administration (FDA or the Agency), ...
The therapy, branded as Itvisma, was approved for the treatment of spinal muscular atrophy patients of age two years and ...
The Trump administration is withdrawing a proposal to require cosmetic companies to test their talc-containing products for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback